Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

FFR-guided PCI linked to better 5-year outcomes than medical therapy

Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) was associated with a 54 percent reduction in the composite endpoint of death, myocardial infarction and urgent revascularization when compared to medical therapy alone, according to five-year data from the FAME 2 trial.

Thumbnail

FDA approves new patient Medication Guides for all GBCAs

The FDA announced its approval of new patient Medication Guides for all gadolinium-based contrast agents (GBCAs) used for MRI, according to a recent press release.

Thumbnail

Can coronary CT angiography accurately evaluate bioresorbable vascular scaffolds? Experts disagree

Coronary CT angiography (CTA) is diagnostically accurate in detecting scaffold luminal obstruction, according to a team of international researchers, signaling it may become the preferred method for evaluating patients treated with bioresorbable vascular scaffold (BVS)—but not all experts agree.

Thumbnail

Fujifilm Introduces New Products, Supports Education, & Exhibits Pulmonary Imaging Portfolio at Ats 2018

FUJIFILM Medical Systems U.S.A., Inc. is exhibiting its portfolio of pulmonary imaging devices at the 114th annual international conference of the American Thoracic Society (ATS) in San Diego, CA, May 18 – 23.

Thumbnail

For perfusion CMR analysis, quantitative tops qualitative for CAD prognosis

Researchers from Germany and the U.K. found quantitative analysis of perfusion cardiac magnetic resonance (CMR) ischemic burden superior to visual analysis in patients with suspected coronary artery disease (CAD), according to a recent Journal of the American College of Cardiology (JACC) study.

New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony

DUBLIN and BOSTON — May 11, 2018 — Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the Micra(TM) Transcatheter Pacing System (TPS) may restore AV synchrony, improving cardiac function in patients with sinus rhythm and atrioventricular (AV) block.

Thumbnail

Cardiac MRI offers better predictions for stable patients with coronary artery disease

A study published May 7 in JACC: Cardiovascular Imaging demonstrates that cardiac magnetic resonance (CMR) imaging improves predictions of major adverse cardiac events in patients who show symptoms for coronary artery disease (CAD), according to an article published May 9 by Cardiovascular Business.

AFib ablation outperforms drugs in CABANA trial

Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.